BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 2756075)

  • 1. Use of the dexamethasone suppression test in an inpatient setting: a replication and new findings.
    Maes M; De Ruyter M; Suy E
    Psychoneuroendocrinology; 1989; 14(3):231-9. PubMed ID: 2756075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Results of the 8 a.m. dexamethasone suppression test constitute a suitable tool for confirming the diagnosis of melancholia. A test unaffected by the variations in the bioavailability of dexamethasone.
    Maes M; Vandewoude M; Schotte C; Cosyns P
    Neuropsychobiology; 1989; 22(1):26-32. PubMed ID: 2639285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The dexamethasone suppression test in the clinical setting.
    Evans DL; Burnett GB; Nemeroff CB
    Am J Psychiatry; 1983 May; 140(5):586-9. PubMed ID: 6342422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Response to dexamethasone in psychotic depression.
    Caroff S; Winokur A; Rieger W; Schweizer E; Amsterdam J
    Psychiatry Res; 1983 Jan; 8(1):59-64. PubMed ID: 6572988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Low-dose (0.5 mg) DST in manic and major depressive episodes: in relation to the severity of symptoms].
    Matsunaga H; Sarai M
    Seishin Shinkeigaku Zasshi; 2000; 102(4):367-98. PubMed ID: 10892305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The dexamethasone suppression test, the Hamilton Depression Rating Scale and the DSM-III depression categories.
    Maes M; De Ruyter M; Hobin P; Suy E
    J Affect Disord; 1986; 10(3):207-14. PubMed ID: 2943774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The dexamethasone suppression test in patients with mood disorders.
    Rush AJ; Giles DE; Schlesser MA; Orsulak PJ; Parker CR; Weissenburger JE; Crowley GT; Khatami M; Vasavada N
    J Clin Psychiatry; 1996 Oct; 57(10):470-84. PubMed ID: 8909334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationships of the dexamethasone suppression test to clinical severity and degree of melancholia.
    Kumar A; Alcser K; Grunhaus L; Greden JF
    Biol Psychiatry; 1986 May; 21(5-6):436-44. PubMed ID: 3697434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An augmented escape of androstenedione from suppression by dexamethasone in melancholia: relationships to intact ACTH and cortisol nonsuppression.
    Maes M; Van Gastel A; Blockx P; Martin M; Cosyns P; Scharpé S; Desnyder R
    J Affect Disord; 1995 Aug; 34(4):291-300. PubMed ID: 8550955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specificity of the salivary cortisol dexamethasone suppression test across psychiatric diagnoses.
    Copolov DL; Rubin RT; Stuart GW; Poland RE; Mander AJ; Sashidharan SP; Whitehouse AM; Blackburn IM; Freeman CP; Blackwood DH
    Biol Psychiatry; 1989 Apr; 25(7):879-93. PubMed ID: 2720003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The clinical use of the dexamethasone suppression test in DSM-III affective disorders: correlation with the severe depressive subtypes of melancholia and psychosis.
    Evans DL; Nemeroff CB
    J Psychiatr Res; 1987; 21(2):185-94. PubMed ID: 3585807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The dexamethasone suppression test in adolescent psychiatric patients.
    Ha H; Kaplan S; Foley C
    Am J Psychiatry; 1984 Mar; 141(3):421-3. PubMed ID: 6703110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Negative symptoms of schizophrenia and the dexamethasone suppression test.
    Garyfallos G; Lavrentiadis G; Amoutzias D; Monas K; Manos N
    Acta Psychiatr Scand; 1993 Dec; 88(6):425-8. PubMed ID: 8310850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The dexamethasone suppression test in adolescent psychiatric inpatients.
    Targum SD; Capodanno AE
    Am J Psychiatry; 1983 May; 140(5):589-91. PubMed ID: 6846588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dexamethasone suppression test (DST) and plasma dexamethasone levels in depressed patients.
    Johnson GF; Hunt G; Kerr K; Caterson I
    Psychiatry Res; 1984 Dec; 13(4):305-13. PubMed ID: 6596587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of depression in a general hospital: utility and limitations of the dexamethasone suppression test.
    Thase ME; Brent DA; Neil JF; Horn TL
    Gen Hosp Psychiatry; 1985 Jan; 7(1):43-8. PubMed ID: 3967824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dexamethasone suppression test: use of two different dexamethasone doses.
    Hwang S; Zander J; Garvey M
    J Clin Psychiatry; 1984 Sep; 45(9):390-2. PubMed ID: 6469924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. L-5-hydroxytryptophan stimulated cortisol escape from dexamethasone suppression in melancholic patients.
    Maes M; D'Hondt P; Martin M; Claes M; Schotte C; Vandewoude M; Blockx P
    Acta Psychiatr Scand; 1991 Apr; 83(4):302-6. PubMed ID: 2028807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An augmented escape of beta-endorphins to suppression by dexamethasone in severely depressed patients.
    Maes M; Jacobs MP; Suy E; Leclercq C; Christiaens F; Raus J
    J Affect Disord; 1990 Mar; 18(3):149-56. PubMed ID: 2139059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The dexamethasone suppression index: enhancement of DST diagnostic utility for depression by expressing serum cortisol as a function of serum dexamethasone.
    Arana GW; Reichlin S; Workman R; Haaser R; Shader RI
    Am J Psychiatry; 1988 Jun; 145(6):707-11. PubMed ID: 3369557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.